Cara Guminik
Vascular Neurology · East Lansing, MINPI 1790300275
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations.
Across 47 payments — averaging $38.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$296
- AbbVie$273
- Penumbra, Inc.$211
- E.r. Squibb & Sons, L.L.C.$188
- Johnson & Johnson$121
- Jazz Pharmaceuticals Inc.$102
- plus $622 from 16 others
What the payments were for
- Food & beverage$1,814100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 10 | $296 |
| AbbVie(2 entities) | 11 | $273 |
| Penumbra, Inc. | 2 | $211 |
| E.r. Squibb & Sons, L.L.C. | 3 | $188 |
| Johnson & Johnson | 1 | $121 |
| Jazz Pharmaceuticals Inc. | 2 | $102 |
| Novo Nordisk | 2 | $94 |
| Route 92 Medical, Inc. | 1 | $93 |
| Medtronic | 1 | $79 |
| Neuropace, Inc. | 1 | $67 |
| Biogen | 2 | $52 |
| Novartis | 1 | $30 |
| Lundbeck LLC | 1 | $29 |
| Tanabe Pharma America, Inc. | 1 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Acorda Therapeutics, Inc | 1 | $21 |
| SK Life Science, Inc. | 1 | $17 |
| Greenwich Biosciences, Inc. | 1 | $17 |
| Argenx US, Inc. | 1 | $16 |
| Bristol Myers Squibb | 1 | $16 |
| AstraZeneca | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEREBASE$121
- RED 72$108
- Nayzilam$106
- Penumbra System$103
How this compares
$1,814 in reported general payments places this provider in the 55th percentile of 29 vascular neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $1,227 |
| Levetiracetam | 25 | $1,180 |
| Lamotrigine | 16 | $396 |
| Donepezil Hcl | 22 | $312 |
| Topiramate | 12 | $224 |
| Atorvastatin Calcium | 19 | $73 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in East Lansing
- Mounzer Yassin KassabEast Lansing$443K
- Anmar RazakEast Lansing$86K
- Syed HussainEast Lansing$610
- Arshad MajidEast Lansing$36
- Aniel MajjhooFlint$432K
- David RosenbaumTraverse City$121K
- Surindar JollyWayne$25K
- Fazeel SiddiquiWyoming$14K
- Dawn KleindorferAnn Arbor$7K
- Daniel MillerDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.